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Abstract 
Purpose: To investigate the antioxidant, hypoglycemic and antidiabetic activities as well as the phenolic 
composition of Ziziphus spina-christi (ZSC) 
Methods: Eighty percent methanol extract (ZSC-1), as well as ethyl acetate (ZSC-2), n-butanol (ZSC-3) 
and aqueous (ZSC-4) fractions were administered orally to mice at doses of 250 and 500 mg/kg of body 
weight. The hypoglycemic and anti-diabetic activities of these fractions in the treated mice were 
evaluated after 7 and 15 days, using glibenclamide as a standard.  Antioxidant activities in vitro were 
determined using stable free radical DPPH and ABTS radical scavenging techniques. 
Results: The strongest (p < 0.001) anti-diabetic activity (25.59 and 39.48 % after 7 and 15 days, 
respectively) was found following treatment with 500 mg/kg ZSC-3 fraction. Similarly, the highest (p > 
0.001) hypoglycemic effect was achieved with 500 mg/kg ZSC-3 treatment (29.07 and 35.56 % after 7 
and 15 days, respectively). ZSC-1 possessed the highest content of total flavonoids (36.2 mg/g) and 
total polyphenol (82.3 mg/g). 
Conclusion: Fraction ZSC-3 displayed potential hypoglycemic activity while ZSC-1, ZSC-2 and ZSC-3 
possess remarkable DPPH scavenging ability equivalent to 89, 96 and 80.3 % of the activity of the 
standard drug respectively.   
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Diabetes mellitus, a metabolic disorder, causes 
damage to the heart, blood vessels, nerves, 
kidney and eyes. The disease may be inherited 
result from a deficiency of insulin   production by 
pancreases and is also related to ineffective 
insulin production. Within the next 25 years, 
diabetes is projected to be one of the major 
causes of death throughout the world. As the 
current effective oral therapy for the treatment of 
diabetes causes side effects, new alternatives 
are required [1].  
 
In modern world, medicinal plants are used to 
treat many diseases, every year, a large 
numbers of novel natural product are isolated 
with efficacy against various diseases. Therefore 
medicinal plants are a potential source of 
therapeutic agents [2]. In this study plants we 
assessed the potential of Zizyphus spina-christi 
which belong to Genus Zizyphus and family 
Rhamnaceae. Ziziphus species are a group of 
small trees that grow in many regions of the 
world. They belong to but are native to 
subtropical and temperate regions.  
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More than forty Ziziphus species are distributed 
widely throughout the Mediterranean, Africa, 
Asia, and tropical America [3]. Ziziphus spina-
christi has grown wild in the southern and 
western regions of the Kingdom of Saudi Arabia 
for many years, but its cultivation has been 
expanded, particularly into the central region of 
the Kingdom. The Arabic name of the plant is 
Sidr or Nabag, and it is used for various 
medicinal purposes. Species of this genus are 
used traditionally for the treatment of various 
diseases such as fever, insomnia, skin infections, 
urinary problems, digestives disorders, obesity, 
liver complaints and diabetes [4].  
 
A clinical study of three species of this genus 
Ziziphus spina-christi, Zizyphus jojoba, and 
Zizyphus vulgaris revealed a great effect on 
insulin secretion. A literature survey revealed that 
a number of terpenoids, flavonoids, isoquinoline 
alkaloids, cyclopeptide, and glycosidic terpenes 
are found in various quantities in almost all 
Ziziphus species. The leaves of the plants in that 
genus contain ceanothic and betulic acids, 
different saponins and flavonoids, triterpenoids 
[5]. Pharmacological screening studies of 
different crude extracts of Zizyphus spina Christi 
showed antidiarrheal [6], central depressant 
effect and antinociceptive effect. Phenolic 
compounds can also act as antioxidants through 
the chelation of metal ions, the preventing of 
radical formation and the improving of the 
antioxidant endogenous system [7]. 
 
Different extracts and fractions from different 
parts of the plants showed bactericidal and 
antiviral activities against different microorganism 
[3]. In the current investigation, we aimed to 
evaluate the composition of the flavonoid and 
polyphenolic compounds in addition to the 
antioxidant and the anti-diabetic activities of the 






The leaves of Ziziphus spina-christi were 
collected from Mecca Road, Jeddah, Saudi 
Arabia in April 2016. The plant was authenticated 
by Prof Kadry Abdelkhalik, Umm Al-Qura 
University, Faculty of Science, Biology 
Department, Meccah, Saudi Arabia. A voucher 
specimen (no. Sh-Am-2016) has been kept in the 




Methanol, n-hexane, chloroform, butanol and 
ethyl acetate were analytical or HPLC grade.  
Folin-Ciocalteu reagent; butylated hydroxyl-
anisole (BHA); quercetin; and gallic acid were 
obtained from Sigma-Aldrich (Germany). 
Streptozotocin and glibenclamide were 
purchased from Sigma (USA) and Spimaco 
(Saudi Arabia) respectively. Other kits used for 
analysis of lipid analysis were purchased from 




The aqueous methanol extract (ZSC-1) was 
obtained by extraction of 1 kg of dried leaf 
powder in 4 L 80 % (v/v) methanol at 25 - 30 0C 
for four days. The filtrate was collected. The 
combined filtrates were concentrated at 45 ºC 
under reduced pressure, using a rotary 
evaporator. To prepare fractions with solvents of 
different polarities, the concentrated aqueous 
solution was defatted with hexane and 
partitioned by solvent extraction using ethyl 
acetate (ZSC-2), and n-butanol (ZSC-3). The 
organic fractions and the residual aqueous 




Swiss albino mice male (20-25 g) of 
approximately  the same age were obtained from 
the Experimental of the Animal Care Center, 
Faculty of Pharmacy, University of King Saud, 
Riyadh, and maintained in controlled conditions 
(temperature, 22 ± 2°C;   humidity, 55 %; 12 : 12 
h light-dark cycle). The mice were provided with 
Purina chow and free access to drinking water. 
Before use, the mice were acclimatized to the 
experimental conditions for 7 days. The study 
was approved (clearance no. CBR-4538) by 
Research Ethics Committee of Experimental 
Animal Care Society, College of Pharmacy, King 
Saud University (Riyadh, Saudi Arabia),  and 
followed the recommendations of the National 
Institutes of Health Guide for Care and Use of 
Laboratory Animals [8] 
   
Induction of streptozotocin-induced 
diabetes 
 
Diabetes was induced by injecting 60 mg/kg 
body weight streptozotocin (STZ) in 0.1M cold 
citrate buffer (pH = 4.5) intraperitoneally. 
Diabetes was confirmed by determining fasting 
blood glucose concentration [9]. The mice were 
divided into six groups of six mice each. Groups I 
and II included untreated diabetic control mice 
and diabetic mice administrated standard (10 
mg/kg/day glibenclamide). Group III, IV, V and VI 
were treated with extracts at the dose level of 
250 mg/kg and 500 mg/kg respectively, for 15 
days. Finally, on day 15, blood was collected for 
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hematological and biochemical parameters. Body 
weight and blood glucose level (with the help of 
Gluco Check) were measured weekly on 
overnight-fasted animals. At the end of the 
experimental period, the animals were fasted 
overnight, blood (0.2 mL) was collected for 
various biochemical analyses, and the animals 
were sacrificed by cervical decapitation.  
 
Evaluation of hypoglycemic and anti-diabetic 
activities 
 
The drugs were administrated at doses of 250 
and 500 mg/kg body weight to each animal. 
Tween 80 (1 mL) was added as a solvent to each 
extract/fraction. The experiment was conducted 
in accordance with a previously reported 
procedure [10]. Briefly, for hypoglycemic 
evaluation, six groups of animals were prepared 
with six mice in each group. Group I was 
administrated normal saline (the diabetic control), 
group II was administered 5 mg/kg glibenclamide 
(standard drug) and groups III, IV, V and VI were 
administered the test extracts or fractions at 250 
and 500 mg/kg body weight.  
 
The extracts, fractions and drugs were orally 
administrated to animals after fasting for 24 h. 
Blood samples were collected before 
administered (zero time) and at 30, 60, 90 and 
120 min after the drugs administered and blood 
glucose level was measured using Reflotron® 
instrument. For anti-diabetic screening, diabetes 
was induced in the overnight fasted animals by 
intraperitoneal injection of 150 mg/kg). The 
induction of diabetes was completed 72 h after 
injection; thereafter the experiment proceeded as 
described for the hypoglycemic experiment. 
 
Glucose tolerance test  
 
All mice were fasted before the experiment. 
Group 1, the diabetic control, was administrated 
1 mL normal saline, group 2 was administered 1 
mg/kg glibenclamide, and the other groups were 
administered ZSC-1, ZSC-2 and ZSC-3 at 250 
and 500 mg/kg, respectively. The animals were 
loaded with glucose (3 g/kg) [11] and blood 
samples were collected immediately before drug 
administration and at 30, 60, 90 and 120 min 
after drug administration.  
 
The serum glucose level was immediately 
specified by using a glucose estimation kit 
Refretron (Roche, Germany) to detect the 
hypoglycemic effects of the tested samples 
compared to the effects of the test samples 
compared to the effects of the standard group 
and control.  
 
Evaluation of biochemical parameters 
 
Triglycerides (TG), cholesterol, lipoprotein high 
density (HDL-C), very low density lipoprotein 
(VLDL-C) and low density lipoprotein (LDL-C) 
were calculated by using Refretron diagnostic kit 
(Roche, Germany). 
  
Determination of total flavonoids 
 
The total content of flavonoids was measured 
using an AlCl3 colorimetric assay, based on the 
method of Zhang et al. [12], with quercetin as a 
reference compound. One milliliter of the sample 
was mixed with methanol extract solution 
containing 2 % AlCl3. The mixture was 
maintained at 30 °C for 15 min to allow the 
formation of a complex between the aluminum 
chloride and the flavonoids. The complex was 
measured at 430 nm using an UV-Vis 
Spectrophotometer (UV-1650 PC, Shimadzu-
Germany). Quercetin concentrations from 00- 
100 mg/L were used to construct a calibration 
curve. Total flavonoid content (TFC) was 
expressed as qurcetin equivalent (QE) in mg/g 
dry weight of plant extract. 
 
Assessment of total phenolic content 
 
The concentration of phenolic content was 
quantified in accordance with the method of 
Shahat et al. [13].  Fifty microliters of the test 
samples were mixed with 2 mL of 2 % sodium 
carbonate and the mixture were maintained at 25 
- 30 oC for 2 min. After the addition of Folin-
Ciocalteau reagent (50 %, 100 µL), the reaction 
was allowed to proceed for 30 min at room 
temperature, after which the absorbance was 
measured at 720 nm. Gallic acid was used to 
construct a standard curve and the phenolic 
content present in the extract was expressed as 




DPPH radical scavenging activity 
 
The effect of the extract, fractions and positive 
control (BHA) on DPPH scavenging free radical 
activity were determined based on the method 
described by Khalifa et al [14] with minor change. 
The stable free radical DPPH was dissolved in 
methanol to produce a 100 µM solution. The 
DPPH solution (3 mL) was added to different 
concentration ranging from 20 - 100 µg/mL of the 
tested samples. One ml of methanol instead of 
the plant extract was used for control.   After 30 
min, the absorbance was measured at 520 nm 
and the DPPH inhibitory activities (D) was 
computed as in Eq 1. 
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D (%) = Ao-(At/Ao)100 …………………. (1) 
 
where At= absorbance of the extract, A0= 
absorbance of control 
 
Determination of ABTS radical scavenging 
activity 
 
The radical scavenging activity of the total extract 
and different fractions of ZSC and the positive 
control, BHA, were measured against the 2, 2-
azino-bis (3-ethylbenzo-thiazoline-6-sulfonic acid 
(ABTS) radical cation by using the method of 
Smeriglio et al and Shahat et al [15]. Aqueous 
solution of 2.45 mmol/L potassium persulfate and 
7 mmol/L of ABTS in water were prepared. The 
two solutions were mixed in a 1:1 v/v ratio and 
stored in the dark for 6 h at room temperature to 
allow production of the ABTS radical. The stock 
solution of ABTS was diluted with methanol.  The 
tested samples were prepared at 5 mg/mL. Serial 
dilutions of the tested samples were prepared 
and the volumes were adjusted to 1mL using 
methanol. ABTS solution was added to different 
concentration of the test samples, mixed strongly 
and incubated at 30 °C for 20 min. The 
absorbance of the solution was recorded at 700 
nm. The affinity of test samples to reaction with 
the ABTS free radical was calculated as in Eq 2.   
 
S (%) = Ao-(At/Ao)100 …………………. (2) 
 
where S, Ao and At are radical scavenging 
activity, absorbance of control and absorbance 




The data are expressed as mean ± standard 
deviation (SD) and were statistically analyzed 
using the one-way analysis of variance (ANOVA) 
or Student’s t-test, followed by Dunnett's multiple 
comparison test. Statistical significance was set 






The blood glucose level after treatment of fasted 
mice with 250 and 500 mg/kg body weight of 
tested fractions after 7 and 15 days are shown in 
Table 1. The anti-diabetic activities increased 
with an increase in the dose of all tested 
fractions. The highest results 25.59 % (7 days) 
and 39.48 % (15 days) were found after the 
administration of 500 mg/kg body weight ZSC-3 
compared with standard drug. These tested 
frictions are further investigated for oral glucose 





The effect of the different plant extracts at a dose 
of 250 and 500 mg/kg body weight on fasting 
blood sugar level were assessed in normal mice 
and the results are summarized in Table 2. The 
highest decrease in glucose level found by ZSC-
3 at 500 mg/kg of body weight was 29.07 % (7 
days) and 35.56 (15 days) compared with 
standard drug. As shown in Table 2, a 
continuous increase can be observed, 
hypoglycemic activities increased with the 
increase in the dose of each friction from 250 to 
500 mg/kg of body weight. The second highest 
decrees of 24.64% (7 days) and 34.85 (15 days) 
were found after treatment with 500 mg/kg of 




The blood glucose level of mice administered 
250 and 500 mg/kg of body weight of all tested 
fractions was investigated after 30, 60, 90 and 
120 min. After the administration of the 
compounds, It was noted that the glucose level 
first increased between 30 to 60 min after 
administration and the decreased between 90 




The measurement of the other parameters such 
as cholesterol, triglyceride HDL, LDL and VLDL 
are presented in Table 4. Here, significant 
changes can be observed in the lipid profiles with 
the tested fraction at both dose levels. A very 
significant change in HDL (96.39 %) was found 
after ZSC-3 treatment and then after ZSC-2 
(71.28 %). both at 500 mg/kg dose level. The 
result (96.39 %) was greater than that observed 
after treatment with the standard drug (95.80 %).  
Fraction ZSC-3 at dose level 500 mg/kg resulted 
in highest LDL (63.49 %) followed by ZSC-2 
(49.16 %). The same fractions also showed the 
highest result for VLDL (29.31 and 24.72 %, 
respectively. At 500 mg/kg bodyweight, the two 
fractions ZSC-3 and ZSC-2 led to a significant 
percentage change in cholesterol and triglyceride 
levels. 
 
Body weight was monitored throughout. After 15 
days, significant change of body weight (*p < 
0.001) were evident after the administration of 
ZSC-2 (500mg/kg) and both doses of ZSC-3 and 
ZSC-4 (Table 5). 
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Table 1: Anti-diabetic activity of extracts on fasting blood glucose level in STZ-induced diabetic mice  
 
Group Dose (mg/kg) 
Before 
treatment Blood glucose concentration (mg/dL) after treatment) 
Day 0 (Mean ± 
S.E.) 
day 7 
 (Mean ± S.E.) % Change 
Day 15th (Mean ± 
S.E.) % Change 
Group I 
Diabetic control  307.50±6.41 317.66±4.13 3.30↑ 315.50±3.87 2.60↑ 
Group II 
Glibenclamide 5 299.16±8.98 158.83±7.80*** 46.90↓ 153.00±3.19*** 48.85↓ 
Group III (ZSC-1 250 315.66±2.49 310.16±3.14 1.74↓ 302.50±3.56* 4.17↓ 500 326.00±9.70 296.66±4.70* 8.99↓ 288.50±6.27* 11.50↓ 
Group III (ZSC-2) 250 318.66±10.76 287.16±4.19* 9.88↓ 277.16±6.06** 13.02↓ 500 305.33±7.68 271.83±3.33** 10.71↓ 201.66±3.92*** 33.95↓ 
Group III (ZSC-3) 250 316.83±11.63 276.00±4.28* 12.88↓ 226.83±7.18*** 28.40↓ 500 315.50±11.13 234.00±5.83*** 25.59↓ 190.33±2.99*** 39.48↓ 
Group III (ZSC-4) 250 326.00±12.29 299.83±4.58 8.02↓ 290.33±11.03 10.94↓    500 331.66±16.54 295.83±6.02 10.80↓ 288.50±3.73* 13.01↓ 
All values represent mean ± SEM; *p < 0.05; **p < 0.01, ***p < 0.001; ANOVA, followed by Dunnett's multiple 
comparison test 
 
Table 2: Hypoglycemic effect of extracts on normal mice treated for two weeks 
 
Group Dose (mg/kg) 
Before 
treatment Blood glucose (mg/dl) post-treatment 
Day 0 
(mean±SE)  day 7(mean±SE) % Change 
Day 15th 
(mean±SE) % Change 
Group I 
Normal saline  109.50±1.70 109.66±2.30 No change 110.83±2.34 No change 
Group II 
Glibenclamide 5 111.66±3.10 62.75±2.50*** 43.80↓ 56.56±2.81*** 49.34↓ 
Group III (ZSC-1) 250 106.16±1.64 100.06±1.50* 5.74↓ 99.93±2.61* 9.16↓ 500 112.33±2.70 99.33±3.74* 11.57↓ 93.13±4.13** 17.09↓ 
Group IV (ZSC-2) 250 109.33±2.26 87.91±2.41*** 19.58↓ 79.38±2.45*** 27.39↓ 500 108.83±2.21 82.01±2.01*** 24.64↓ 70.90±1.30*** 34.85↓ 
Group V  (ZSC-3) 250 102.33±3.26 88.06±1.70** 13.94↓ 83.00±1.61*** 18.89↓ 500 109.83±1.99 77.90±2.81*** 29.07↓ 70.76±2.21*** 35.56↓ 
Group VI (ZSC-4) 
250 107.00±3.11 108.83±2.92 No change 108.00±1.82 No change 
500 107.83±1.79 101.63±1.71* 5.74↓ 98.33±1.89** 8.80↓  
All values represent mean ± SEM. *p < 0.05;**p < 0.01, ***p < 0.001; ANOVA, followed by Dunnett's Multiple 
comparison tests  
 
Table 3: Effect of extract fractions on oral glucose tolerance (OGT) in mice 
 
Group Dose (mg/kg) 
Before 
treatment Blood glucose level post-treatment 
(0 h) 30 min 60 min 90 min 120 min 
Group I Normal saline  117.33±2.92 298.33±5.18*** 347.66±6.18*** 249.66±6.40*** 224.00±9.54*** 
Group II Glibenclamide 5 115.50±3.55 195.66±5.55*** 169.50±4.92*** 151.83±3.27*** 131.50±2.76** 
Group III (ZSC-1) 250 112.00±2.89 282.50±6.98*** 310.50±17.65*** 270.33±7.84*** 216.83±10.77*** 500 112.00±2.70 298.83±5.24*** 323.83±6.72*** 234.33±7.33*** 208.50±3.12*** 
Group IV (ZSC-2) 250 115.00±2.23 289.33±6.40*** 314.00±7.35*** 213.16±5.53*** 199.00±5.05*** 500 115.50±2.77 289.50±5.50*** 339.83±6.28*** 189.16±6.06*** 173.33±5.88*** 
Group V (ZSC-3) 250 117.33±3.92 261.16±9.60*** 317.83±5.36*** 223.16±6.59*** 168.33±6.04*** 500 115.66±1.76 178.16±7.73*** 316.83±7.12*** 180.66±7.73*** 153.00±4.15*** 
Group VI  (ZSC-4) 250 118.83±3.10 279.50±6.11*** 320.33±5.22*** 283.00±6.56*** 216.16±3.29*** 500 112.83±2.13 294.16±4.52*** 324.66±5.32*** 242.66±7.14*** 193.66±6.13*** 




The total flavonoid content of the extract and 
fractions were measured by using the AlCl3 
assay; the results are presented in Figure 1. The 
flavonoid content was highest in 80 % methanol 
extract (ZSC-1, 36.2 mg/g), followed by ethyl 
acetate (ZSC-1, 31.2 mg/g), n-butanol (ZSC-3, 
28.2 mg/g), and the aqueous fraction (ZSC-4, 
24.6 mg/g). ZSC-1 showed the highest flavonoid 
content, followed by ZSC-2 and ZSC-3 extracts; 
ZSC-4 showed the lowest flavonoid content. 
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Table 4: Effect of extract on lipid profile of STZ-induced diabetic mice 
 
Group Dose (mg/kg) 
Cholesterol (mg/dL) Triglycerides (mg/dL) HDL (mg/dL) LDL(mg/dL) VLDL (mg/dL) 
Mean ± SE % Change Mean ± SE 
% 
Change Mean ± SE 
% 
Change Mean ± SE 
% 
Change Mean ± SE 
% 
Change 
Normal saline  102.02 ± 2.65  100.41± 2.79  54.58±2.12  27.36± 2.79  20.08±0.55  
Gp I diabetic  209.83±4.41a 105.65 193.33±3.15***a 92.53 22.63±0.97***a 54.53 148.53±3.9***a 442.75 38.66±0.63***a 92.53 
Gp II glibenclamide 5 120.66±3.56***b 42.49 115.66±2.27***b 40.17 44.31±2.05***b 95.80 53.21±3.87***b 64.17 23.13±0.45***b 40.17 
Gp III 
(ZSC-1) 
250 201.66±4.52 3.89 183.83±5.15b 4.91 22.46±1.03b  142.43±4.6b 4.10 36.76±1.03b 4.91 
500 192.66±3.39*b 8.18 179.16±4.54*b 7.32 26.91±1.02*b 18.92 129.91±3.8**b 12.53 35.83±0.98*b 7.32 
Group IV 
(ZSC-2) 
250 171.16±4.18***b 18.42 171.00±2.19***b 11.55 30.36±1.08***b 34.16 106.6±4.45***b 28.23 34.20±0.43***b 11.55 
500 143.33±2.34***b 31.69 145.33±2.45***b 24.82 38.76±1.09***b 71.28 75.5±3.02***b 49.16 29.06±0.49***b 24.72 
Gp V 
(ZSC-3) 
250 157.66±4.36***b 24.86 159.00±3.89***b 17.75 31.85±0.99***b 40.72 94.01±4.81***b 36.70 31.80±0.77***b 17.75 
500 126.00±2.42***b 39.95 136.66±3.21***b 29.31 44.45±4.65***b 96.39 54.21±4.40***b 63.49 27.33±0.64***b 29.31 
Group VI 
(ZSC-4) 
250 209.33±4.85b - 195.33±3.95b - 23.98±0.73b 5.96 146.28±4.01b  39.06±0.79b  
500 193.836±7.08b 7.62 187.50±5.45b 3.10 29.30±0.87***b 29.45 127.03±8.2*b 14.47 37.50±1.09b 3.01 
Gp, Group; All values represent mean ± SEM; *p < 0.05; **p < 0.01, ***p < 0.001; ANOVA, followed by Dunnett's multiple comparison test; a compared with normal group; b 
compared with diabetic group 
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Table 5: Effect of extract on body weight in STZ-induced diabetic mice 
 
Group Dose (mg/kg) 
day 0 (before treatment) 15 Days (post-treatment) % Change (mean ±SE) (mean ±SE) 
Normal  (Saline)  20.90 ± 0.64 24.63±0.30*** 17.86 
Group I (Diabetic)  22.36 ± 0.58 19.96±0.55*** 24.14↓ 
Group II 
(Glibenclamide) 5 22.00 ± 0.40 26.55±0.36*** 20.68↑ 
Group III (ZSC-1) 
 
250 22.40 ± 0.39 20.45±0.73* 8.70↓ 
500 22.60 ± 0.28 20.88±0.46* 7.59↓ 
Group IV (ZSC-2) 250 22.95 ± 0.73 24.70±0.25* 7.62↑ 500 22.05 ± 0.50 24.61±0.22*** 11.64↑ 
Group V (ZSC-3) 250 21.11 ± 0.43 24.58±0.28*** 16.41↑ 500 20.93 ± 0.34 25.13±0.23*** 20.06↑ 
Group VI (ZSC-4) 
250 20.81 ± 0.58 19.06±0.53 8.40↓ 
500 22.50 ± 0.31 17.66±0.56*** 21.48↓  




Figure 1: Total flavonoid content of the total extract 
and different fractions of Ziziphus spina-christi  
 
Total polyphenolic content  
 
The total phenolic contents of Z. spina-christi 
were measured by the Folin-Ciocalteu assay of 
Singleton et al [16] and Shahat et al [13] and 
reported as mgGallic Acid equivalents (GAE) per 
g of sample. As shown in Figure 2, the total 
extract, ZSC-1, had the highest phenolic content 
(82.3 mg/g), followed by ZSC-2, ZSC-3, and 
ZSC-4 at 76.3, 73.6, and 68.3 mg/g respectively. 
ZSC-4 had the lowest total phenol content. 
 
 
Figure 2: Polyphenolic content of total extract and 




Antioxidant has been used widely in food 
industry to prolong the shelf life. Antioxidant term 
refers to a compound that can be inhibited or 
delay the oxidation of biomolecules. A numerous 
number of plant extracts have been investigated 
for their antioxidant activities [13,17]. The 
secondary metabolite compounds of the higher 
plants have been verified in in vitro experiments 
to defend against oxidative damage through 
reduction or inhibition of the free radicals and 
oxygen reactive species.  
  
DPPH radical scavenging activity 
 
Five concentrations of the tested samples were 
used with the positive control; the activities were 
increased as the concentration increases.  The 
total extract (ZSC-1) and the fractions ZSC-2, 
ZSC-3, and ZSC-4 exhibited strong antiradical 
activity by reducing the radical stable DPPH to 
yellow colored (Figure 3) in comparison with the 
positive control (BHA) which is a known 
antioxidant. The Ethyl acetate fraction (ZSC-2) 
exhibited higher DPPH scavenging activity (96 
%) compared with the standard, ZSC-3 and ZSC-
4. ZSC-4 fraction showed lowest activity at 100 
µg/mL. A concomitant Increase in scavenging 
activity with an increase in concentration. The 
hydrophobic DPPH free radical change in 
scavenging capacity of the extract and different 
fraction of Zizyphus spina-christi is shown in 
Figure 3. 
 
Total antioxidant capacity 
 
The blue and green ABTS radical cation was 
generated before the addition of the antioxidant 
and the degree of radical cation decolorization 
can be used to measure the relative antioxidant 
ability of extract compared to that of BHA, The  
Al-Ghamdi & Shamhat 
Trop J Pharm Res, November 2017; 16(11): 2608  
 
 
Figure 3: Free radical scavenging activity (DPPH) of ZSC-1 and the different fractions (ZSC-2, ZSC-3, and ZSC-
4) of Ziziphus spina-christi at different concentrations 
 
 
Figure 4: Radical-scavenging activity of extract and fractions from Ziziphus spina-christi at different 
concentrations 
 
total antioxidant capacity of total extract and 
different fractions of Zizyphus spina christi at 
different concentration, measured by using the 
ABTS, is shown in Figure 4. A concentration-
dependent increase in scavenging was 
observed. ZSC-4 showed lowest ABTS 
scavenging activity. The total antioxidant 
activities of ZSC-1, ZSC-2, ZSC-3 and ZSC-4 




Streptozotocin-induced hyperglycemia has been 
described as a useful model to study the activity 
of hypoglycemic agents. Streptozotocin 
selectively   destroys the pancreatic β cells, 
reduce their activity, and cause diabetes [18]. 
In the present study, significant weight loss was 
observed in the diabetic group in addition to an 
improvement in the weight of rats in the diabetic 
group treated with fraction ZSC-3. This may be a 
result of the ability of the extracts to reduce 
hyperglycemia in STZ induced diabetes, which is 
characterized by severe body weight loss, owing 
to the loss or degradation of structural protein 
[19].  
 
In the present study, blood glucose levels were 
four times higher than the initial level after the 
induction of diabetes. However, treatment with 
ZSC-3 fraction reduced blood sugar level 
compared with levels of the control. The ZSC-3 
fraction was more effective in controlling the 
blood glucose level than the other tested 
samples. This activity may be attributable to the 
presence of saponins glycosides [5]. Many 
studies have shown the blood glucose-lowering 
effect of plant extracts such as Boehmeria 
rugulosa [20], and have sought to evaluate the 
hypoglycemic effect in STZ- and alloxan-induced 
diabetes mellitus. Hyperlipidemia is a recognized 
complication of diabetes mellitus, characterized 
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by elevated levels of cholesterol, triglycerides 
and changes in lipoprotein composition.  
 
In the present study, significant hyperlipidemia 
was observed in STZ-induced rats compared to 
the normal groups. However, administration of 
the fractions reduced the hyperlipidemia. ZSC-3 
was found to be the most effective, followed by 
ZSC-2 which indicated that these fractions had 
the potential to improve insulin secretion. 
Similarly, many authors have also noticed 
hypercholesterol and hypertriglycerides condition 
[21], which supported the data in the present 
study. The total flavonoids content and 
polyphenol contents of ZSC-1, ZSC-2, ZSC-3 
and ZSC-4 were 36.2, 31.2, 28.2 and 24.6 mg/g 
and 76.3 mg/1g, 73.6 mg/1g and 68.3 mg/1g 
respectively. The ethyl acetate (SZC-2) fraction 
showed DPPH scavenging activity greater than 
the standard compound (96 %); the activities of 
ZSC-1, ZSC-3 and ZSC-4 were 89, 80.3 and 
77.3 %, respectively. The total antioxidant 
activities of ZSC-1, ZSC-2, ZSC-3 and ZSC-4 





Fraction ZSC-3 showed potential hypoglycemic 
activity in diabetic mice. ZSC is rich in flavonoids 
and polyphenols, which may be responsible for 
its strong antioxidant effect. Further studies are 







This study was supported by the Deanship of 
Scientific Research (DSR), King Abdulaziz 
University, Jeddah (grant no. D-033-363-1437). 
The authors gratefully acknowledge this support. 
 
Conflict of Interest 
 
No conflict of interest associated with this work. 
 
Contribution of Authors 
 
The authors declare that this work was done by 
the authors named in this article and all liabilities 
pertaining to claims relating to the content of this 
article will be borne by them.  
 
Open Access  
 
This is an Open Access article that uses a fund-
ing model which does not charge readers or their 
institutions for access and distributed under the 
terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/ 
4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/rea
d), which permit unrestricted use, distribution, 
and reproduction in any medium, provided the 




1. Malviya N, Jain S, Malviya S.  Antidiabetic potential of 
medicinal plants. Acta Pol Pharm AbdEl-Sala NM, Riaz 
Ullah. In Vitro Antimicrobial Bioassays, DPPH Radical 
Scavenging Activity, and FTIR Spectroscopy Analysis of 
Heliotropium bacciferum. Biomed Res Int 2016; 2016: 1-
12. 
2. Shahat  AA, Pieters L, Apers S, Nazeif NM, Abdel-Azim 
N, Vanden Bergh D, Vlietinck AJ. Chemical and 
biological investigation of Zizyphus spina-cristi. 
Phytother Res 2001; 15: 593-597. 
3. Abdel-Zaher AO, Salim SY, Assaf MH, Abdel-Hady RH. 
Antidiabetic activity and toxicity of Zizyphus spina-christi 
leaves. J Ethnopharmacol.2005; 101: 129-138. 
4. Niamat R, Khan MA, Khan KY, Ahmed M, Mazari P, Ali 
B, Mustafa M, Zafar M. A review on Zizyphus as 
antidiabetic J App Pharmacol Science 2012; 02 (03): 
177-179 
5. Adzu B, Amos S, Amizan MB, Gamaniel K. Evaluation of 
the antidiarrheal effects of Zizyphus spina-christi stem 
bark in rats. Acta Tropica. 2003; 7: 245–250.  
6. Seyuum A, Asres K, El-Fiky FK. Structure radical 
scavenging activity relationships of flavonoids. 
Phytochemistry. 2006; 67: 2058-2070. 
7. NIH Guide for the Care and Use of Laboratory Animals. 
Revised (1985). NIH Publication Number. 85-23, U.S. 
Department of Health, Education and Welfare. Research 
Triangle Park, North Carolina. 
8. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. 
Combination of high-fat diet-fed and low-dose 
streptozotocin-treated rat: a model for type 2 diabetes 
and pharmacological screening. Pharmacol. Res 2005; 
52: 313–320.  
9. El Tahir KA. Guide to drug discovery: Directions for 
pharmacological screening for new synthetic and natural 
compounds leading to discovery of new medicines. 
Riyadh, El Tahir Publication, 2007; 100-105. 
10. Hemant P, Sharma S, Khajja BS, Jain K, Jain GC. 
Evaluation of hypoglycemic and antihyperglycemic 
potential of Tridax procumbens Linn. BMC Complement 
Altern Med. 2009; 9: 48. 
11. Zhang H, Li X, Wu K, Wang M, Liu P, Wang X, Deng R. 
Antioxidant activities and chemical constituents of 
flavonoids from the flower of Paeonia ostia. Molecules. 
2017; 22: 5. 
12. Shahat AA, Ibrahim AY, Alsaid MS. Polyphenolic Content 
and Antioxidant Activity of Some Wild Asteraceae Plants 
Asian Pac J Trop Med 2014; 7 (7): 554-551. 
Al-Ghamdi & Shamhat 
Trop J Pharm Res, November 2017; 16(11): 2610  
 
13. Khlifi SH, Ben Jemaa H, Ben Hmad H, Abaza H, 
Karmous I. Abid A, Benzarti A, Elati J, Aouidet A. 
Antioxidant, antidiabetic and antihyperlipidemic effects 
of Trigonella foenum-graecum seeds. Int. J. Pharmacol. 
2016; 12: 394-400. 
14. Shahat AA, Ibrahim AY, Alsaid MS. Antioxidant capacity 
and polyphenolic content of seven Saudi Arabian 
medicinal herbs traditionally used in Saudi Arabia Indian 
J_Tradit_Know 2015; 1 (1): 28-35  
15. Singleton VL, Orthofer R,  Lamuela-Raventos RM, 
Analysis of total phenols and other oxidation substrates 
and antioxidants by means of Folin Ciocalteu reagent. 
Methods Enzymol. 1999; 299: 152-178. 
16. Shahat AA, Nazif NM, Abousetta LM, Ibrahim NA, Cos P, 
Van Miert S, Pieters L, Vlietinck AJ, Phytochemical 
investigation and antioxidant activity of Duranta repens. 
Phytother. Res. 2005; 19: 1071-1073. 
17. Szkudelski T. The mechanism of alloxan and 
streptozotocin action in B cells of the rat pancreas. 
Physiol Res 2001; 50:536-546 
18. Veeramani C, Pushpavalli G, Pugalendi KV.  In vivo 
antioxidant and hypolipidemic effect of Cardiospermum 
halicacabum leaf extract in streptozotocin-induced 
diabetic rats. J. Basic Clin. Physiol. Pharmacol., 2010; 
21(2): 107–125 
19. Semwal DK, Rawat U, Semwal R, Singh R,  Krishan  P, 
Singh M,  Singh  G. Chemical constituents from the 
leaves of Boehmeria rugulosa with antidiabetic and 
antimicrobial activities. J Asian Nat Prod Res 2010; 11: 
1045-1055 
20. Venkatesh S, Dayanand RG,  Madhava R. 
Antihyperglycemic and hypolipidemic effects of 
Helicteres isora roots in alloxan induced diabetic rats 
Pharmaceut Biol 2010; 5: 347-350 
 
